Prelude Therapeutics Incorporated Common Stock (PRLD)

$4.12 +3.91%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE

Since Aug 12, 2021, Prelude Therapeutics Incorporated Common Stock (PRLD) has reported earnings 20 times. On average the shares move ±7.58% post-earnings, with a positive reaction 50.0% of the time. Its largest post-earnings gain was +32.71% (Feb 15, 2024) and its largest decline was -7.02% (Nov 14, 2022). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.58%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 12, 2026	☀ PRE	$4.90	$4.93	$4.64	7,083	-3.33%	open_in_new
Mar 10, 2026	☀ PRE	$3.19	$3.62	$3.57	11,805	+16.29%	open_in_new
Nov 12, 2025	☀ PRE	$1.40	$1.47	$1.46	2,602	+8.15%	open_in_new
Aug 14, 2025	☀ PRE	$0.92	$0.92	$0.92	601	+1.14%	open_in_new
May 06, 2025	☽ POST	$0.79	$0.79	$0.78	1,077	+0.17%	open_in_new
Mar 10, 2025	☀ PRE	$0.70	$0.70	$0.69	4,697	-4.83%	open_in_new
Nov 06, 2024	☽ POST	$1.30	$1.33	$1.31	1,598	-3.8%	open_in_new
Aug 12, 2024	☀ PRE	$5.03	$5.03	$4.82	2,786	-4.84%	open_in_new
May 07, 2024	☀ PRE	$3.71	$3.71	$3.71	120	-3.76%	open_in_new
Feb 15, 2024	☽ POST	$3.54	$3.56	$3.47	1,532	+32.71%	open_in_new
Nov 01, 2023	☽ POST	$1.70	$1.92	$1.85	8,596	+19.95%	open_in_new
Aug 03, 2023	☀ PRE	$3.63	$3.63	$3.58	1,348	-4.53%	open_in_new
May 08, 2023	☀ PRE	$6.24	$6.26	$6.19	1,234	-4.92%	open_in_new
Mar 15, 2023	☀ PRE	$5.62	$6.61	$6.57	2,680	+7.88%	open_in_new
Nov 14, 2022	☀ PRE	$8.37	$8.52	$7.95	3,858	-7.02%	open_in_new
Aug 09, 2022	☀ PRE	$6.26	$6.55	$6.55	4,878	+1.08%	open_in_new
May 10, 2022	☀ PRE	$4.13	$4.54	$4.40	19,089	+10%	open_in_new
Mar 16, 2022	☀ PRE	$7.36	$7.87	$7.73	14,783	+8.57%	open_in_new
Nov 12, 2021	☀ PRE	$17.00	$17.00	$16.23	27,851	-3.28%	open_in_new
Aug 12, 2021	☽ POST	$32.42	$34.05	$34.05	4,417	-5.37%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

8 most recent

Form	Date Filed	View on EDGAR
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
8-K	20260610	open_in_new SEC.gov
CORRESP	20251215	open_in_new SEC.gov

Frequently asked about PRLD earnings

When does Prelude Therapeutics Incorporated Common Stock report earnings next? expand_more

Prelude Therapeutics Incorporated Common Stock (PRLD)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PRLD stock move after earnings? expand_more

Over 20 reports, PRLD has moved an average of ±7.58% the session after earnings, closing higher 50.0% of the time.

What was PRLD's biggest post-earnings move? expand_more

PRLD's largest post-earnings gain on record was +32.71% on Feb 15, 2024, and its largest decline was -7.02% on Nov 14, 2022.

Where can I find Prelude Therapeutics Incorporated Common Stock's SEC filings? expand_more

All of Prelude Therapeutics Incorporated Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.